top of page
Screenshot 2023-06-13 180949.png
  • Writer's pictureThe Beagle

Recall of EpiPen 300 - 20 March 2017

Recall of EpiPen 300 - 20 March 2017

All EpiPens with an April 2017 expiry date are being recalled because of a possible defect that may result in difficulty activating the device in an emergency.

This recall is being conducted by Alphapharm in consultation with the Australian Therapeutic Goods Administration(TGA). Alphapharm Initiates Recall of EpiPen® Auto-Injector in Australia EpiPen® 300 microgram (μg) Adrenaline Injection Syringe Auto-InjectorBatches 5FA665, 5FA6651, 5FA6652, 5FA6653 Alphapharm Pty Ltd, following consultation with the Therapeutic Goods Administration, is recalling the following batches of EpiPen® 300 microgram (μg) Adrenaline Injection Syringe Auto-Injectors due to the potential that these devices may contain a defective part that may result in the device failing to activate or requiring increased force to activate. Batch number Expiry 5FA665 Apr 17 5FA6651 Apr 17 5FA6652 Apr 17 5FA6653 Apr 17

Information provided as per Allergy & Anaphylaxis Australia (A&AA) website media releases More information HERE and HERE

NOTE: Comments were TRIALED - in the end it failed as humans will be humans and it turned into a pile of merde; only contributed to by just a handful who did little to add to the conversation of the issue at hand. Anyone who would like to contribute an opinion are encouraged to send in a Letter to the Editor where it might be considered for publication

bottom of page